Artificial Disc Patent Case Could Define Shape Of The Market
This article was originally published in The Gray Sheet
Executive Summary
Pending patent litigation between Medtronic and Spine Solutions could shape the artificial disc replacement market for years to come, according to Tram Anh Nguyen, VP of intellectual property at orthopedic consulting firm MCRA
You may also be interested in...
Medtronic Prestige Cervical Disc Rollout Marks 800 Surgeons Trained To Date
Medtronic has trained over 800 surgeons to date on the use of its Prestige artificial cervical disc and will train 200 more each weekend "for the next several weeks," the firm reported Aug. 21 during its fiscal 2008 first quarter earnings call
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.